期刊文献+

妊娠期糖尿病胎盘组织血管内皮生长因子、基质金属蛋白酶-9和Ⅳ型胶原的表达及意义 被引量:2

Expression and significance of vascular epithelial growth factor and matrix metalloproteinase-9 and type Ⅳ-collagen in gestational diabetic placenta
原文传递
导出
摘要 目的探讨血管内皮生长因子(VEGF)、基质金属蛋白酶-9(MMP-9)和Ⅳ型胶原(Ⅳ-C)在妊娠期糖尿病(GDM)胎盘中的表达及其与GDM治疗的关系。方法选择2007年6月至12月在太原市妇幼保健医院住院分娩的GDM孕妇48例为GDM组,取同期分娩的正常晚期妊娠妇女36例为对照组,用免疫组织化学法测定VEGF、MMP-9及Ⅳ-C在胎盘中的表达并比较其表达情况。结果(1)GDM组胎盘VEGF、MMP-9及Ⅳ-C的阳性表达率明显高于对照组(70.8%和30.6%,64.6%和30.6%,62.5%和27.8%,P值均〈0.05);(2)GDM组内血糖控制不满意者胎盘VEGF、MMP-9及Ⅳ-c的阳性表达率分别为95.2%、80.9%和85.7%,明显高于对照组(P%0.05);血糖控制满意组分别为51.9%、51.9%和44.4%,与对照组比较差异无统计学意义(P〉0.05);(3)GDM组胎盘MMP-9的表达与VEGF和Ⅳ-C的表达均呈正相关(r=0.579,P〈0.01;F=0.596,P〈0.01)。结论GDM胎盘组织中VEGF、MMP-9及Ⅳ-C的高表达与孕妇血糖控制水平有关。 Objective To investigate the expression and clinical significance of vascular epithelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) and type Ⅳ-collagen(Ⅳ- C) in gestational diabetic placenta. Methods A case-control study was performed in 48 women with gestational diabetes mellitus (GDM) and 36 healthy pregnant women (control), who delivered at Taiyuan Maternal and Infant Health Care Hospital from Jun. 2007 to Dec. 2007. The expressions of VEGF, MMP-9 and Ⅳ-C in placenta were detected by immunohistochemistry. Results The expression of VEGF, MMP-9 and Ⅳ-C in GDM placenta was significantly higher than that of control (70.80% vs 30.6%,64.6% vs 30. 6% ,62.5% vs 27.8%,all P〈0.05). For those GDMs whose blood glucose levels were well controlled, the expression of VEGF, MMP-9 and Ⅳ-C (51.90%, 51.9% and 44. 4%) showed no difference from the control (P〉0.05), however, those GDMs which were poor- controlled, the expression of the three indicators (95.2%, 80.9% and 85.7%) were higher than the control (P〈0.05). The expression of MMP-9 was positively correlated with that of VEGF and Ⅳ-C in the GDM group(r= 0. 579, P〈0.01 ; r= 0. 596, P〈0.01). Conclusions The high expression of VEGF, MMP-9 and Ⅳ-C in GDM placenta may be associated with blood glucose control. Early management of the blood sugar level might alleviate the pathological changes in placenta.
出处 《中华围产医学杂志》 CAS 2009年第5期338-341,共4页 Chinese Journal of Perinatal Medicine
关键词 糖尿病 妊娠 胎盘 免疫组织化学 血管内皮生长因子A 基质金属蛋白酶9 胶原Ⅳ型 Diabetes, gestational Placenta Immunohistochemistry Vascular endothelialgrowth factor A Matrix metalloproteinase 9 Collagen type Ⅳ
  • 相关文献

参考文献11

  • 1Hod M, Jovanovie L, Di Renzo GC, et al. Textbook of diabetes and pregnancy. London: Martin Dunitz, 2003 : 64-80.
  • 2武海荣,杨慧霞.妊娠期糖尿病基因多态性研究进展[J].国际妇产科学杂志,2009,36(1):20-22. 被引量:11
  • 3Yokoi M, Yamagishi SI, Takeuehi M, et al. Elevations of AGE and vascular Endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic Patients with retinopathy. Br J Ophthalmol, 2005,89 : 673-675.
  • 4Kim NH,Jung HH, Cha DR,et al. Expression of vascular endothelial growth factor in response to high glucose in rat rnesangial cells. J Endocrinol, 2000,165 : 617-624.
  • 5仇杰,张玉芳,周敏.胰岛素样生长因子-1与妊娠期糖尿病的临床研究[J].中国妇幼保健,2008,23(18):2505-2507. 被引量:6
  • 6Death AK, Fisher EJ, McGrath KC, et al. High glucose alters matrix metalloproteinase expression in two key vascular cells:potential impact on atherosclerosis in diabetes. Athero sclerosis, 2003,168 : 263-269.
  • 7Jin M, Kashiwagi K, Iizuka Y, et al. Matrix metalloproteinases in human diabtic and nondiabetic vitreous. Retina, 2001,21: 28-33.
  • 8于璟,王善菊,曹慧玲,赵明.尿Ⅳ型胶原与糖尿病微血管病变的关系[J].放射免疫学杂志,2003,16(2):80-81. 被引量:3
  • 9Cohen MP, Lautenslager GT, Shearman CW, et al. Increased urinary type Ⅳ collagen marks the development of glomerular pathology in diabetic d/db mice. Metabolism, 2001,50 :1435-1440.
  • 10Bergers G, Brekken R, McMahon G, et al. Matrix metallo proteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol, 2000,2:737-744.

二级参考文献12

  • 1牛海英,牛秀敏.胰岛素样生长因子-I与妊娠关系的研究进展[J].国外医学(妇产科学分册),2004,31(4):238-240. 被引量:6
  • 2任伟,张素华,邱鸿鑫,汪志红,兰帆,粟绍初,李萍.血清IV型胶原水平与2型糖尿病微血管病变的关系[J].中华内分泌代谢杂志,1998,14(2):137-138. 被引量:13
  • 3Wang HS, Chard T. The role of insulin - like growth factor - 1 and insulin - like groqth fsctor - binding protein - 1 in the control of human fetal growth. J Endocrinol, 1992, 132:11.
  • 4Lauszus FF, Klebe JG, Flyvbjerg A et al. Macrosomia associated with maternal serum insulin - like growth factor - Ⅰ and Ⅱ in diabetes pregnancy. Obstet Gynecol, 2001, 97 (5pt1): 734.
  • 5William D. Ehringer,Ou-Li Wang,Adeel Haq,Frederick N. Miller. Bradykinin and α-Thrombin Increase Human Umbilical Vein Endothelial Macromolecular Permeability by Different Mechanisms[J] 2000,Inflammation(2):175~193
  • 6N. Shaat,?. Lernmark,E. Karlsson,S. Ivarsson,H. Parikh,K. Berntorp,L. Groop. A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus[J] 2007,Diabetologia(5):972~979
  • 7N. Shaat,E. Karlsson,?. Lernmark,S. Ivarsson,K. Lynch,H. Parikh,P. Almgren,K. Berntorp,L. Groop. Common variants in MODY genes increase the risk of gestational diabetes mellitus[J] 2006,Diabetologia(7):1545~1551
  • 8N. Shaat,M. Ekelund,?. Lernmark,S. Ivarsson,P. Almgren,K. Berntorp,L. Groop. Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus[J] 2005,Diabetologia(12):2544~2551
  • 9N. Shaat,M. Ekelund,?. Lernmark,S. Ivarsson,A. Nilsson,R. Perfekt,K. Berntorp,L. Groop. Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus[J] 2004,Diabetologia(5):878~884
  • 10Z. Wenyi,Dr. S. Suzuki,M. Hirai,Y. Hinokio,Y. Tanizawa,A. Matsutani,J. Satoh,Y. Oka. Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects[J] 2003,Diabetologia(7):972~976

共引文献28

同被引文献33

  • 1侯秀红,李东红,李怡,赵宏喜,张春利,黄亮,姚元庆.跨膜型血管内皮生长因子受体1在子痫前期患者胎盘组织中的表达及其意义[J].中华妇产科杂志,2006,41(11):736-739. 被引量:1
  • 2刘宝瑛,简奕婪,钟梅,余艳红,王前,张军.妊娠晚期糖尿病孕妇止凝血功能指标检测的临床意义[J].南方医科大学学报,2007,27(1):35-37. 被引量:14
  • 3巫小燕,沈飞霞.粒细胞集落刺激因子作用研究进展[J].医学综述,2007,13(12):909-911. 被引量:5
  • 4Redman CWG,Sargent IL. Latest advance in understanding preeclampsia. Science, 2005,308 (5728) : 1592-1594.
  • 5Sibai B,Dekker G,Kupherming M. Pre-eclampsia. Lancet, 2005,365(9461 ) :785-799.
  • 6Chedraui P, Lockwood CJ,Schatz F, et al. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia. Matern Fetal Neonatal Med, 2009,6:1-6.
  • 7Shama A,Satyam A,Shama JB. Leptin,IL-10 and inflammatory markers in pre-eelamptie,nomotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol,2007,58 ( 1 ) : 21 - 30.
  • 8Seolh J,Oh M J, Lee K J, et al. Urinary angiogenie factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol,2004,191(6) : 14.
  • 9Muy-Rivera M, Vadachkoria S, Woelk GB, et al. Maternal plasma VEGF, sVEGF-RI,and PIGF concentrations in preeclamptie and nomotensive pregnant Zimbabwean women. Physiol Res,2005,54 (6) :611-622.
  • 10Merviel P, Carbillon L, Challier JC,et al. Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol, 2004,115 (2) : 134-147.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部